Associated Papers
Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex.
Yuan L et al.
Cancer Discovery, 2025
State-selective small molecule degraders that preferentially remove aggregates and oligomers.
Luptak J et al.
Nature Communications, 2025
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders.
Lu P et al.
Cell, 2024
Select a paper to view details